APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaled Nitric Oxide Therapy Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Inhaled Nitric Oxide Therapy Solutions Market Outlook and Growth Opportunities 2026

23 December 2025195 pages

Choose your research edition.

Industry ResearchInhaled Nitric Oxide Therapy Solutions Industry Research Report 2026103 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled Nitric Oxide Therapy Solutions Industry Growth and Trends Forecast to 203261 pages · $3,450 USDMarket StructureGlobal Inhaled Nitric Oxide Therapy Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled Nitric Oxide Therapy Solutions Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled Nitric Oxide Therapy Solutions Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Inhaled Nitric Oxide Therapy Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Inhaled Nitric Oxide Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhaled Nitric Oxide Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhaled Nitric Oxide Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Inhaled Nitric Oxide Therapy Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Inhaled Nitric Oxide Therapy Solutions market include Air Liquide, Linde and Mallinckrodt, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Inhaled Nitric Oxide Therapy Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhaled Nitric Oxide Therapy Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhaled Nitric Oxide Therapy Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Inhaled Nitric Oxide Therapy Solutions market.

Inhaled Nitric Oxide Therapy Solutions Segment by Company

Air Liquide

Linde

Mallinckrodt

Inhaled Nitric Oxide Therapy Solutions Segment by Type

iNO Gas

Inhaled Nitric Oxide Delivery System

Inhaled Nitric Oxide Therapy Solutions Segment by Application

Hospitals

Other Healthcare System

Inhaled Nitric Oxide Therapy Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Inhaled Nitric Oxide Therapy Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Inhaled Nitric Oxide Therapy Solutions key companies, revenue, market share, and recent developments.

3. To split the Inhaled Nitric Oxide Therapy Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Inhaled Nitric Oxide Therapy Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhaled Nitric Oxide Therapy Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Inhaled Nitric Oxide Therapy Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled Nitric Oxide Therapy Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled Nitric Oxide Therapy Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled Nitric Oxide Therapy Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhaled Nitric Oxide Therapy Solutions industry.

Chapter 3: Detailed analysis of Inhaled Nitric Oxide Therapy Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Inhaled Nitric Oxide Therapy Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Inhaled Nitric Oxide Therapy Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhaled Nitric Oxide Therapy Solutions Industry Trends Table 2. Inhaled Nitric Oxide Therapy Solutions Industry Drivers Table 3. Inhaled Nitric Oxide Therapy Solutions Industry Opportunities and Challenges Table 4. Inhaled Nitric Oxide Therapy Solutions Industry Restraints Table 5. Global Inhaled Nitric Oxide Therapy Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhaled Nitric Oxide Therapy Solutions Revenue Share by Company (2021-2026) Table 7. Global Inhaled Nitric Oxide Therapy Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Inhaled Nitric Oxide Therapy Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Inhaled Nitric Oxide Therapy Solutions Company, Product Type & Application Table 10. Global Inhaled Nitric Oxide Therapy Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Inhaled Nitric Oxide Therapy Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of iNO Gas Table 15. Significant Companies of Inhaled Nitric Oxide Delivery System Table 16. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type (2021-2026) Table 20. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Other Healthcare System Table 23. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application (2021-2026) Table 27. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application (2027-2032) Table 28. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Region (2021-2026) Table 31. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Region (2027-2032) Table 33. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Market Share by Country (2021-2026) Table 36. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Market Share by Country (2027-2032) Table 38. Air Liquide Company Information Table 39. Air Liquide Business Overview Table 40. Air Liquide Inhaled Nitric Oxide Therapy Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Air Liquide Inhaled Nitric Oxide Therapy Solutions Product Portfolio Table 42. Air Liquide Recent Development Table 43. Linde Company Information Table 44. Linde Business Overview Table 45. Linde Inhaled Nitric Oxide Therapy Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Linde Inhaled Nitric Oxide Therapy Solutions Product Portfolio Table 47. Linde Recent Development Table 48. Mallinckrodt Company Information Table 49. Mallinckrodt Business Overview Table 50. Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Product Portfolio Table 52. Mallinckrodt Recent Development Table 53. Research Programs/Design for This Report Table 54. Authors List of This Report Table 55. Secondary Sources Table 56. Primary Sources List of Figures Figure 1. Inhaled Nitric Oxide Therapy Solutions Product Image Figure 2. Global Inhaled Nitric Oxide Therapy Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled Nitric Oxide Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhaled Nitric Oxide Therapy Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. iNO Gas Image Figure 8. Inhaled Nitric Oxide Delivery System Image Figure 9. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Other Healthcare System Image Figure 14. Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application (2021-2032) Figure 17. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Inhaled Nitric Oxide Therapy Solutions Sales Value (2021-2032) & (US$ Million) Figure 20. North America Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Inhaled Nitric Oxide Therapy Solutions Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Inhaled Nitric Oxide Therapy Solutions Sales Value (2021-2032) & (US$ Million) Figure 26. South America Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • iNO Gas
  • Inhaled Nitric Oxide Delivery System
Applications
  • Hospitals
  • Other Healthcare System
Companies covered
  • Air Liquide
  • Linde
  • Mallinckrodt

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inhaled Nitric Oxide Therapy Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inhaled Nitric Oxide Therapy Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Inhaled Nitric Oxide Therapy Solutions Market Dynamics
  1. 2.1 Inhaled Nitric Oxide Therapy Solutions Industry Trends
  2. 2.2 Inhaled Nitric Oxide Therapy Solutions Industry Drivers
  3. 2.3 Inhaled Nitric Oxide Therapy Solutions Industry Opportunities and Challenges
  4. 2.4 Inhaled Nitric Oxide Therapy Solutions Industry Restraints
3 Inhaled Nitric Oxide Therapy Solutions Market by Company
  1. 3.1 Global Inhaled Nitric Oxide Therapy Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Inhaled Nitric Oxide Therapy Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Inhaled Nitric Oxide Therapy Solutions Company Ranking (2024-2026)
  4. 3.4 Global Inhaled Nitric Oxide Therapy Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Inhaled Nitric Oxide Therapy Solutions Company Product Type and Application
  6. 3.6 Global Inhaled Nitric Oxide Therapy Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Inhaled Nitric Oxide Therapy Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Inhaled Nitric Oxide Therapy Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Inhaled Nitric Oxide Therapy Solutions Market by Type
  1. 4.1 Inhaled Nitric Oxide Therapy Solutions Type Introduction
  2. 4.1.1 iNO Gas
  3. 4.1.2 Inhaled Nitric Oxide Delivery System
  4. 4.2 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Type
  5. 4.2.1 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Type (2021-2032)
  7. 4.2.3 Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type (2021-2032)
5 Inhaled Nitric Oxide Therapy Solutions Market by Application
  1. 5.1 Inhaled Nitric Oxide Therapy Solutions Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Other Healthcare System
  4. 5.2 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Application
  5. 5.2.1 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Application (2021-2032)
  7. 5.2.3 Global Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application (2021-2032)
6 Inhaled Nitric Oxide Therapy Solutions Regional Value Analysis
  1. 6.1 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inhaled Nitric Oxide Therapy Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Inhaled Nitric Oxide Therapy Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Inhaled Nitric Oxide Therapy Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Country, 2025 VS 2032
7 Inhaled Nitric Oxide Therapy Solutions Country-level Value Analysis
  1. 7.1 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Inhaled Nitric Oxide Therapy Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Inhaled Nitric Oxide Therapy Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Inhaled Nitric Oxide Therapy Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Air Liquide
  2. 8.1.1 Air Liquide Company Information
  3. 8.1.2 Air Liquide Business Overview
  4. 8.1.3 Air Liquide Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Air Liquide Inhaled Nitric Oxide Therapy Solutions Product Portfolio
  6. 8.1.5 Air Liquide Recent Developments
  7. 8.2 Linde
  8. 8.2.1 Linde Company Information
  9. 8.2.2 Linde Business Overview
  10. 8.2.3 Linde Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Linde Inhaled Nitric Oxide Therapy Solutions Product Portfolio
  12. 8.2.5 Linde Recent Developments
  13. 8.3 Mallinckrodt
  14. 8.3.1 Mallinckrodt Company Information
  15. 8.3.2 Mallinckrodt Business Overview
  16. 8.3.3 Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mallinckrodt Inhaled Nitric Oxide Therapy Solutions Product Portfolio
  18. 8.3.5 Mallinckrodt Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst